Xingfang Su
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 2
- Advanced Drug Delivery Systems 1
- Surfaces, Coatings and Films top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 2
-
- HIV Research and Treatment 1
-
- HIV/AIDS Research and Interventions 1
-
- Microbial Inactivation Methods 1
- Co-authors
- Darrell J. IrvineDaniel G. KavanaghPaula T. HammondByeong‐Su KimNicole YangK. Dane WittrupMadhavan NallaniLucia Mori
- Journals
- Advanced Materials (2 papers)Journal of Materials Chemistry B (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Xingfang Su
11 papers receiving 417 citations
Peers
Comparison fields: 5 of 63
- Pharmaceutical Science 67
- Surfaces, Coatings and Films 68
- Biomaterials 98
- Immunology 86
- Molecular Biology 255
Countries citing papers authored by Xingfang Su
This map shows the geographic impact of Xingfang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfang Su more than expected).
Fields of papers citing papers by Xingfang Su
This network shows the impact of papers produced by Xingfang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfang Su. The network helps show where Xingfang Su may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Xingfang Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Analysis on willingness to pay for HIV antibody saliva rapid test and related factors]. | 2015 | 2 |
| 2 | 2013 | 18 | |
| 3 | 2013 | 1 | |
| 4 | 2013 | 11 | |
| 5 | In vitro and in vivo mRNA delivery using lipid-enveloped pHresponsive polymer nanoparticles | 2011 | 7 |
| 6 | 2011 | 236 | |
| 7 | 2010 | 3 | |
| 8 | 2010 | 1 | |
| 9 | 2009 | 131 | |
| 10 | 2006 | 6 | |
| 11 | 2004 | 5 |
About Xingfang Su
Xingfang Su is a scholar working on Pharmaceutical Science, Biomaterials and Virology, having authored 11 papers that have together received 421 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Advanced Drug Delivery Systems (1 paper), HIV Research and Treatment (1 paper), HIV/AIDS Research and Interventions (1 paper) and Microbial Inactivation Methods (1 paper). The work is most often cited by research in Pharmaceutical Science (67 citations), Surfaces, Coatings and Films (68 citations) and Biomaterials (98 citations). Xingfang Su has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Darrell J. Irvine, Daniel G. Kavanagh, Paula T. Hammond, Byeong‐Su Kim, Nicole Yang, K. Dane Wittrup, Madhavan Nallani, Lucia Mori, Xinlu Cheng and Peter C. DeMuth. Their work appears in journals such as Advanced Materials, Journal of Materials Chemistry B, Molecular Pharmaceutics, ACS Nano and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.